Former Australian cricketer Chris Lynn received a one-month suspension from the ECB’s Cricket Regulator following a positive drug test. The sample, collected during the T20 Blast finals day on July 18, revealed the presence of benzoylecgonine, a metabolite of cocaine. The violation prompted an immediate response from cricket authorities, leading to a period of ineligibility that concluded on August 30. On July 31, Cricket Regulator notified Lynn about the findings of the drug test and conveyed to him that he was provisionally suspended.
Technical analysis performed at the WADA-accredited Laboratoire Anti-Dopage in France confirmed the findings. Under the 2026 WADA Prohibited List, cocaine is classified as a stimulant and specifically categorized as a Substance of Abuse. Following notification of these results on July 31, Lynn was placed under a provisional suspension. He subsequently responded to the charge on August 20, acknowledging that he had ingested the substance on July 15 and 16.
During the regulatory process, Lynn maintained that the consumption occurred out of competition and was entirely unrelated to his athletic performance. He provided supporting evidence to substantiate this claim, which was ultimately accepted by the Cricket Regulator when they issued a formal charge notice on September 23. Although the regulatory body initially sought a three-month ban, the duration was shortened to one month after Lynn confirmed his participation in a substance of abuse treatment program.
The legal proceedings saw two initial charges brought against the batter, though one was eventually dropped because the concentration of the substance in his urine fell below the threshold required for a WADA-level violation. Because the suspension was backdated to the start of his provisional period on July 31, the sanction was considered served by the end of August. Lynn, who was representing Northamptonshire during the tournament, accepted the final decision without further challenge.
